ISPOR 2026

1 minute read

Published: March 5th, 2026

Phastar is delighted to be attending ISPOR US, 17-20 May in Philadelphia, PA

Connect to meet with our team on site or stop by our posters:

Evaluation of the Role of Clinical Unmet Need in Health Technology Assessment Decision-making of Oncology Trials Without Demonstrated Overall Survival Benefits Due to Treatment Crossover
Poster Session Date/Time: Monday, 18 May, 10:30 am – 1:30 pm
Discussion Period: 12:30 PM – 1:30 PM
Billy Amzal, Head of Strategic Consulting

Role of Real-World Evidence in Supporting and Validating Crossover Adjustments of Overall Survival in Oncology Trials: A Systematic Literature Review of Health Technology Assessments of Treatments for Selected Tumors
Poster Session Date/Time: Wednesday, 20 May, 9:00 AM – 11:30 AM
Discussion Period: 9:00 AM – 10:00 AM
Billy Amzal, Head of Strategic Consulting

Related articles

OCT Europe 2026

OCT Europe 2026

March 8th, 2026 1 minute read

Phastar is delighted to be exhibiting at the OCT Europe, 6-7 May in Barcelona, Spain. Visit the Phastar exhibit at bo...

PHUSE SDE, Beijing 2026

PHUSE SDE, Beijing 2026

March 6th, 2026 1 minute read

Phastar is delighted to be attending PHUSE SDE, 15 May in Beijing, China. Connect to meet with our team on site or jo...

CEN 2026

CEN 2026

March 4th, 2026 1 minute read

Phastar is delighted to be attending CEN, 18-21 May in Warsaw, Poland. Connect to meet with our team on site and visi...